Pharming Group N.V. (PHAR)

Pharming Group Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	12.85	-8.49	-12.01	14.99	23.08
Depreciation & Amortization	11.22	16.07	15.93	13.19	19.61
Stock-Based Compensation	13.77	11.25	9.25	6.39	9.06
Other Adjustments	16.93	-2.37	-13.61	-17.95	-10.82
Change in Receivables	-3.36	-6.78	-18.54	2.36	5.92
Changes in Inventories	-1.29	-0.5	-14.43	-15.02	-6.15
Changes in Accounts Payable	17.82	-2.77	16.23	11.99	-5.19
Changes in Other Operating Activities	-5.32	-10.4	2.01	-0.88	0.52
Operating Cash Flow	54.71	-1.8	-17.3	22.46	37.84
Operating Cash Flow Growth	-	-	-	-40.65%	-54.75%
Capital Expenditures	-0.75	-0.79	-1.44	-1.38	-10.74
Purchases of Intangible Assets	-0.01	-0.01	-0.03	-0.6	-5.98
Purchases of Investments	-0.74	-284.31	-382.01	-	-4.59
Proceeds from Sale of Investments	85.23	316.73	232.81	7.3	-
Payments for Business Acquisitions	-57.48	-	-	-	-
Other Investing Activities	-	-	21.28	-	-
Investing Cash Flow	26.25	31.62	-129.39	5.32	-21.31
Long-Term Debt Issued	-	104.54	-	-	-
Long-Term Debt Repaid	-	-134.92	-	-	-
Net Long-Term Debt Issued (Repaid)	-	-30.39	-	-	-
Issuance of Common Stock	19.81	5.58	8.13	2.28	4.72
Net Common Stock Issued (Repurchased)	19.81	5.58	8.13	2.28	4.72
Other Financing Activities	-10.44	-9.61	-9.17	-7.26	-32.67
Financing Cash Flow	1.5	-34.41	-1.04	-4.98	-27.95
Net Cash Flow	82.45	-4.59	-147.73	22.8	-11.41
Free Cash Flow	53.96	-2.59	-18.74	21.08	27.1
Free Cash Flow Growth	-	-	-	-22.21%	-65.68%
FCF Margin	14.35%	-0.87%	-7.64%	10.25%	13.63%
Free Cash Flow Per Share	-	-0.03	-0.26	0.30	0.39
Levered Free Cash Flow	24.53	-40.62	7.75	21.59	14.04
Unlevered Free Cash Flow	-37.28	-396.59	-245.95	-170.15	-111.79

Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q